RxDoctor Payments Data

Jesse Jensen, DO

Dermatology · Tooele, UTNPI 1619294337

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 257 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations.

$5,203in general payments, 2019–2025

Across 257 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$580
  • AbbVie$579
  • UCB, Inc.$577
  • Novartis$422
  • Regeneron Healthcare Solutions, Inc.$389
  • Johnson & Johnson$330
  • plus $2K from 22 others
$284,210in research payments, 2019–2025

Across 42 payments — averaging $6766.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$220K
  • AbbVie$64K

What the payments were for

  • Food & beverage$5,203100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,203 in reported general payments places this provider in the 75th percentile of 163 dermatology providers in Utah.

See all dermatology providers in Utah

Medicare billing

Part B allowed, 2024
$219,640
Medicare patients
378
Services billed
8,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira PenAdalimumab14$97,412
Dupixent PenDupilumab13$48,646
XolairOmalizumab12$32,703
Clobetasol Propionate75$3,656
Fluorouracil27$1,920
Ketoconazole108$1,828
Desonide29$1,340
Metronidazole21$981
Doxycycline Monohydrate27$672
Clindamycin Phosphate15$471
Minoxidil40$466
Econazole Nitrate14$415
Hydrocortisone34$390
Minocycline Hcl12$296
Imiquimod15$288

Paid to pharmacies, not to this prescriber.

Other dermatology in Tooele

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →